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Introduction
Cyclooxygenase-2 (COX-2) produces prostaglandins through oxygenation of arachidonic acid. Numerous functions and pathological phenomena have been attributed to the products of COX-2 in the central nervous system. Most notably, COX-2 is upregulated in response to excitotoxicity or tissue damage. This pathological process leads to an increase in prostaglandin levels and additional neuronal damage (For review, see (Yang and Chen, 2008) ).
In healthy nervous systems, COX-2 is constitutively expressed with localization primarily in the hippocampus, cortex, and amygdala (Yamagata et al., 1993) . On a subcellular level, COX-2 immunoreactivity (COX-2 IR) is primarily in the perikarion and proximal dendrites (Yamagata et al., 1993) . Electron microscopy studies localized rat brain COX-2 to endomembranes in dendrites near synaptic inputs from axon terminals (Wang et al., 2005) .
Constitutive COX-2 activity and expression mediates long term potentiation (LTP) in mice (Chen et al., 2002) and rats Akaneya and Tsumoto, 2006) and depression (LTD) in rats (Murray and O'Connor, 2003) . The promotion of LTP by COX-2 likely results from prostaglandin E2 activation of the prostaglandin E2 receptor, as nimesulide-induced reductions of LTP in the mouse dentate gyrus can be rescued by administering prostaglandin E2 (Chen et al., 2002) , and receptor gene suppression reduces LTP in the visual cortex (Akaneya and Tsumoto, 2006) . Overall, COX-2's localization pattern, along with its association with synaptic plasticity suggests a major role for this enzyme in the processes of learning and memory (For review, see (Yang and Chen, 2008) ).
In addition to metabolizing arachidonic acid, COX-2 oxygenates endocannabinoids, producing prostamides and prostaglandin glycerol esters (Yu et al., 1997; Kozak et al., 2002 ).
This discovery is not surprising, as endocannabinoids are structurally similar to arachidonic acid, This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on November 5, 2016 jpet.aspetjournals.org Downloaded from JPET #168831 5 and the omega fatty acid portion of molecules from both groups interacts effectively with amino acids in COX-2's active site (Kozak et al., 2003) Although the endogenous production of oxygenated endocannabinoid products by COX-2 is well documented, the functions of these recently discovered signaling molecules and their receptor targets are still being elucidated. The first study showing a signaling role for an oxygenated endocannabinoid reported that prostaglandin E2 glycerol ester, an oxidative metabolite of 2-arachidonoylglycerol (2-AG), significantly increased miniature inhibitory postsynaptic current frequency in cultured hippocampal neurons (Sang et al., 2006) . In a subsequent publication, the same authors showed in hippocampal cultures that PGE2-G enhances excitatory glutamatergic synaptic transmission and promotes neurodegeneration (Sang et al., 2007) . To date, it is not known what receptor(s) compounds such as PGE2-G activate. It is interesting to note, however, that these oxidative products act in direct opposition to endocannabinoids, which have long been shown to exhibit neuroprotective effects (For review, (Galve-Roperh et al., 2008) .
Although COX-2 metabolizes endocannabinoids, it is widely accepted that endogenous cannabinoids are primarily hydrolyzed by fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL). FAAH is widely distributed throughout the mouse brain (Egertova et al., 2003) and efficiently metabolizes the endocannabinoids anandamide (AEA) and 2-AG. Transgenic mice lacking FAAH possess elevated endogenous AEA levels, suggesting that FAAH is the principal metabolizing enzyme of AEA in the mouse (Cravatt et al., 2001; Lichtman et al., 2002) . A recently published manuscript has demonstrated that activitydependent changes in AEA tone mediate the selective "local tuning" of hippocampal inhibitory synapses (Kim and Alger, 2010) . The observed changes in AEA tone were regulated by This article has not been copyedited and formatted. The final version may differ from this version.
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While COX-2 is not considered a major endocannabinoid metabolizing enzyme, the oxygenation of endocannabinoids is physiologically important, as COX-2 inhibition potentiates rat hippocampal 2-AG signaling (Kim and Alger, 2004) . Therefore, COX-2 likely regulates hippocampal endocannabinoid tone and may compete with FAAH and/or MGL for endocannabinoid substrates.
In this study, we employed a novel ex vivo FAAH imaging technique (Glaser et al., 2006) and the selective COX-2 inhibitor nimesulide to examine whether endogenous COX-2 activity competes with FAAH for [
3 H]AEA metabolism in the brains of live mice. A previous report identified nimesulide as having no effects upon FAAH activity (Fowler et al., 2003) . We examined eleven brain regions in order to expand upon prior work (Kim and Alger, 2004; that was restricted to hippocampal neurons possessing high endogenous expression of COX-2, FAAH and MGL. In addition, we analyzed temporal changes in COX-2 expression and localization in mouse brains by conducting experiments at the midpoint of the light and dark cycles, and studied whether temporal changes in COX-2 distribution affected regional [ 3 H]AEA metabolism.
Methods
Animals:
C57BL/6 mice (Taconic Farms, Germantown, NY) weighing approximately 25g were kept in LD 12:12. Mice were studied at the midpoint of the light and dark cycle. All mice were This article has not been copyedited and formatted. The final version may differ from this version. JPET #168831 7 maintained with free access to food and water according to the federal guidelines for the care and use of animals. These studies followed international guidelines on the ethical use of animals in research, with animal numbers and their suffering kept to a minimum. These studies were approved by the Institutional Review Committee.
Regional COX-2 western blots:
At the midpoint of the light and dark period, regional brain dissections were performed on six mice in each time point, and tissue homogenized in chilled Tris + 1mM EDTA + complete
Mini EDTA acid -free protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany).
Once protein concentrations were determined by BCA protein assay (Pierce Chemical, Rockford, IL), samples (40 μg of protein/lane) were run on a 10% SDS-PAGE gel. Following transfer to a nitrocellulose membrane at 100V for 25 min, blots were blocked in 5% non-fat dry milk in PBS Tween (PBST) for one hour and probed for one hour with polyclonal rabbit COX-2 antibody directed against aa 584-598 of murine COX-2 (catalog # 160126 lot # 155350 Cayman Chemical, Ann Arbor, MI) at a final concentration range of 1:100 to 1:400 or monoclonal mouse anti-β actin antibody directed against aa 1-14 of Xenopus laevis actin (AbCam, Inc. Cambridge, MA) at a final concentration of 1:20,000. The blots were rinsed three times with phosphate buffered saline tween-20 (PBST) followed by incubation with goat anti-mouse or goat anti-rabbit IgG horse radish peroxidase -conjugated antibodies (Molecular Probes, Eugene, OR) for 1 hour.
Following three rinses with PBST, blots were developed using the Immun-star HRP substrate (Bio-Rad, Hercules, CA) and exposed to film. Temporal changes in regional COX-2 protein levels were determined by normalizing COX-2 levels to β -actin levels within the same lane, and
This article has not been copyedited and formatted. The final version may differ from this version. 
COX-2 immunolocalization:
Wild-type C57BL/6 mice were kept at LD12:12. Six hours after the onset of the light or dark period ('noon' and 'midnight', respectively), mice were deeply anesthetized and perfused with 3% formaldehyde in saline. Brains were isolated and post-fixed for another 4 hours in 3% paired 2-Tailed T-test using Excel (Microsoft). Data were graphed using GraphPad Prism 4 (GraphPad Software Inc., San Diego, CA).
In vitro FAAH enzyme activity assays:
Six hours after the onset of the light and dark period, regional brain dissections were performed on six mice for each time point. Following tissue homogenization in Tris + 1mM
EDTA on ice, protein concentrations were determined by BCA protein assay (Pierce Chemical, Rockford, IL). FAAH activity assays were performed according to published methods (Deutsch and Chin, 1993) . Briefly, 300 µg of regional homogenate, 500 µg fatty acid-free bovine serum albumin, 100 µM AEA (Cayman Chemical, Ann Arbor, MI) plus 0.22 µCi arachidonoyl ethanolamide [ethanolamine-1-3H] (a generous gift from the National Institute on Drug Abuse, Bethesda, MD) were incubated in Tris + 1mM EDTA pH 7.6 at 37°C in triplicate for fifteen minutes while shaking. The reactions were terminated by the addition of 2 volumes of 1:1 chloroform/methanol. Samples were centrifuged, and the aqueous phase measured by liquid scintillation counting. The rates of AEA hydrolysis/mg protein/ hr were compared between noon and midnight regional homogenates. Data were graphed and significance determined by unpaired 2-Tailed T-test with a Bonferroni's correction using GraphPad Prism 4 (GraphPad Software Inc.).
Ex vivo autoradiography of brain FAAH activity:
Radiolabeled AEA [arachidonoyl 5,6,8,9,11,12,14,15- promptly transferred to a beaker containing iced saline, in order to minimize further diffusion and protein-mediated processes. Half of the cerebellum and a blood sample were homogenized, extracted in 1:1 chloroform:methanol, and analyzed by scintillation counting and thin layer chromatography (solvent system was 6:3:1 ethylacetate:hexane: acetic acid (Deutsch and Chin, 1993) ), in order to quantify total tritium accumulation, and [ 3 H]AEA breakdown in these tissues.
Chilled brains were transferred into iced 2% formaldehyde + 2% glutaraldehyde in phosphate buffer for one hour. The brains were then washed three times with iced phosphate buffer, and cryoprotected at 4°C in 30% sucrose in PB. Serial 15µm cryosections were generated, and images acquired for ten hours using the BetaImager (Biospace, Paris, France).
Autoradiography analysis:
Serial sections were analyzed, and surface radioactivity (cpm/mm 2 ) in regions of interest quantified using BetaVision+ image analysis software (Biospace Mesures, Paris, France). Data were entered into Excel (Microsoft Corp., Seattle, WA), and average regional tritium accumulation/mm 2 , representing AEA and its metabolites, was determined. Six mice were used for each condition. Regional surface activities of each mouse were normalized by dividing the activity of each region over that of the pontine nuclei (the region of lowest tritium accumulation) of the same mouse. Normalization enabled regional comparison among animals with slightly different levels of brain tritium uptake. Standard error was calculated using Excel. Data were graphed, and one-way analysis of variance with Dunnett's post test was performed to determine significance between noon and midnight samples using GraphPad Prism 4 (Graph Pad Software
Inc.).
Quantitative real time polymerase chain reaction (qRT-PCR):
At the midpoint of the light and dark period, regional dissections were performed on six mice and RNA extracted using the RNeasy mini kit (Qiagen, Valencia, CA). One microgram of RNA was subjected to cDNA synthesis using the Superscript III first strand synthesis kit Negative controls lacking cDNA were included for all reactions. Amplification levels were determined using the delta delta Ct method with β -actin serving as the housekeeping gene.
Results
Temporal changes in COX-2 distribution
The regional distribution of COX-2 was compared at noon and midnight by western blot (Fig.1) . A control western blot against whole brain homogenate showed one band at ~75 kDa, which was not detected in cerebellar homogenates, or in whole brain homogenates following preadsorption with immunizing peptide (Fig. 1A and B ). Brains were harvested at the midpoint of the light and dark cycle, and regional dissections performed. The cortex, hippocampus, striatum, This article has not been copyedited and formatted. The final version may differ from this version. 1C ). Increases in COX-2 protein levels were observed in midnight hippocampal samples (p<0.05) (Fig. 1D) . Quantitative real-time PCR (qRT-PCR) corroborated the elevated expression of COX-2 in midnight hippocampi (p<0.05) compared to noon samples (Fig. 2) . COX-2 mRNA was also detected in cortical, striatal, and thalamic samples, although their levels did not vary (p>0.05) with a temporal pattern.
As temporal changes in COX-2 protein and mRNA levels were detected, we performed immunohistochemistry on brains collected at noon and midnight to detect potential temporal changes in COX-2 immunoreactive cell populations. COX-2 immunoreactivity (COX-2 IR) was most robust in the hippocampus and various cortical regions, including the piriform cortex, somatosensory cortex, and visual cortex (Fig. 3) . In the somatosensory and visual cortices ( Fig. 3A-H), COX-2 IR was observed in laminae II, II, V, and VI. When comparing noon and midnight brain samples, changes in COX-2-IR cortical populations were observed, with a higher (p<0.01) ratio of immunoreactive profiles in laminae II/III relative to laminae V/VI in midnight somatosensory cortex and visual cortex samples (Table 1) . Therefore, although COX-2 expression does not increase in the cortex, COX-2 distribution in the somatosensory and visual cortices change, with additional profiles exhibiting COX-2 IR at midnight.
Several other brain regions exhibited robust COX-2 IR, including the piriform cortex ( Fig. 3I and J) , hippocampus ( Fig. 3K-P) , and amygdala ( Fig. 3Q and R) . In the hippocampus ( Fig. 3K-P 
Nimesulide administration inhibits COX-2 but not FAAH in the brain
To discern between FAAH and COX-2 activity, we imaged brains following i.p.
administration of vehicle or nimesulide, a selective competitive COX-2 inhibitor. Prior to conducting brain imaging studies, we determined the degree of nimesulide penetration into the brain following i.p. administration with an in vitro COX-2 activity assay. We harvested brains at 15 to 45 minutes following the i.p. administration of 25 mg/kg nimesulide or vehicle.
Endogenous COX-2 activity in healthy brain was too low to detect by in vitro enzymatic assays (data not shown). In contrast, purified COX-2 activity was readily detectable. Therefore, the presence of nimesulide in brains was determined by the brain homogenates' ability to inhibit purified COX-2 in an in vitro activity assay. Compared to vehicle-treated homogenates, purified COX-2 activity was significantly reduced (p<0.05) in nimesulide-treated homogenates that were generated at least 30 minutes following i.p. administration (Fig. 5) . These data indicate that ample nimesulide had entered the brain under the assay conditions selected for the autoradiography experiments. We next conducted in vitro FAAH activity assays using the same nimesulide-treated and control homogenates. We detected no difference in regional activity between control and nimesulide-treated samples (Fig. 6) 
Ex vivo autoradiography
We used autoradiography to examine the impact of COX-2 inhibition upon regional (Fig. 8) . Nimesulide administration also caused an increase in noon PAG tritium accumulation. These data suggest that competition between FAAH and COX-2 for AEA may serve as a point of regulation for brain AEA signaling in numerous regions.
Competition for substrate necessitates close proximity between enzymes within the same brain region. As expected, the COX-2 IR pattern in C57BL/6 mice is similar to both the distribution of COX-2 in rat brains (Yamagata et al., 1993; Wang et al., 2005) , and the distribution of FAAH in C57BL/6 mice (Egertova et al., 2003) . Both COX-2 (Fig. 3 ) and FAAH immunoreactivity (FAAH IR) (Egertova et al., 2003) immunoreactivity, although COX-2 IR is primarily concentrated in CA2 and CA3. FAAH IR was also prominent in most thalamic nuclei. Although COX-2 IR was not detected in this region (Fig. 3) , both COX-2 protein ( Fig. 1) and mRNA ( Fig. 2) were detected, suggesting low levels of the enzyme exist in the thalamus. It is noteworthy that regions consistently exhibiting nimesulide-dependent increases in tritium accumulation (Fig. 8 ) express both COX-2 and FAAH (Egertova et al., 2003) . These data suggest that FAAH and COX-2 are sufficiently co-localized to compete for [ 3 H]AEA substrate in these brain regions.
The autoradiography assay used in this manuscript more closely mimics endogenous AEA metabolism than in vitro enzyme assays providing an excess of substrate. Through autoradiography analysis, regions with robust COX-2 expression, such as the hippocampus, exhibit no more dramatic differences between control and COX-2-inhibited states than the To date, all physiology studies that show COX-2's influence over endogenous cannabinoid signaling have studied the hippocampus (Kim and Alger, 2004; , the brain region exhibiting the most robust COX-2 expression. Our data reveal that even regions with modest COX-2 expression can exhibit competition between COX-2 and FAAH for [ 3 H]AEA substrate. For example, although thalamic COX-2 protein levels are too low to detect by immunofluorescence (Fig. 3) , its enzymatic inhibition is sufficient to potentiate This article has not been copyedited and formatted. The final version may differ from this version. endocannabionid / endovanilloid signaling could be much more extensive than previously believed, and suggests that more physiology studies of these systems should be conducted to better ascertain COX-2's influence upon these endogenously produced signaling molecules.
Prostamides and prostaglandin glycerol esters have distinct signaling properties from both endocannabinoids and prostaglandins and do not interact with cannabinoid or prostaglandin receptors (For review, see Woodward et al., 2008) . As expected these compounds have distinct pharmacological properties, with prostamides regulating intraocular pressure (Woodward et al., 2008) and stimulating cat iris contraction (Matias et al., 2004) , and glyceryl prostaglandins mediating calcium mobilization, inositol 1,4,5-trisphosphate synthesis, and activation of protein kinase C in RAW264.7 macrophage cells (Nirodi et al., 2004) . The data presented in this study suggest that nimesulide can be used to inhibit prostamide production. Not only does this increase substrate availability to FAAH, it also likely could inhibit several prostamide-mediated processes in the body.
We observed temporal changes in COX-2 expression in healthy mouse brains. Relative to noon, western blot ( Fig. 1 ) and qRT-PCR (Fig. 2) analyses revealed an increase in COX-2 expression in hippocampal samples at midnight. Although the levels of COX-2 protein and mRNA did not vary, immunohistochemistry studies (Fig. 3) detected shifts in immunoreactive cell populations in the somatosensory and visual cortices between noon and midnight, with more immunoreactive cells in lamina II and III of midnight samples.
The temporal changes in COX-2 IR observed in the current study were generally too slight to alter the regional distribution pattern of [ 3 H]AEA metabolites between noon and midnight samples (Fig. 8) . Only the somatosensory cortex exhibited a significant change between the two time points, with the midnight nimesulide condition exhibiting significantly less effect relative to midnight control samples than noon nimesulide samples. At first glance, the autoradiography data would appear to contradict the immunoreactivity data (Fig. 3 ) that exhibits an increase in the number of COX-2 IR cells at midnight. However, the pattern of COX-2 IR cells changes in the somatosensory cortex between noon and midnight, and this change in distribution may result in COX-2 becoming more remote from FAAH near specific synaptic connections at midnight, thereby lessening the competition between the two enzymes for substrate.
Similar to COX-2, FAAH exhibits temporal changes in brain expression and activity. In a prior publication (Glaser and Kaczocha, 2009) , we observed that FAAH activity in the mouse cerebellum and PAG fluctuated temporally, with reductions in regional activity observed in the middle of the dark cycle of the mice. Temporal changes in regional FAAH activity were monitored during this study, and were carefully discerned from any nimesulide-induced changes in regional [ 3 H]AEA metabolism. It should be noted that significant reductions in FAAH activity can alter the sensitivity of the autoradiography assay in some brain regions. For example, although PAG tritium accumulation was significantly potentiated by nimesulide at noon, nimesulide exhibited no effect in midnight PAG (Fig. 8) . This is likely due to reduced midnight PAG FAAH activity (Glaser and Kaczocha, 2009 ) diminishing the sensitivity of the imaging assay in the PAG at midnight.
When results from the current study are grouped with prior reports demonstrating potentiation of 2-AG signaling in the hippocampus following COX-2 inhibition (Kim and Alger, 2004; , the potential regulatory role of COX-2 in endocannabinoid signaling becomes even more apparent. We predict that systemic nimesulide administration Significance was determined by an unpaired two-tailed t-test. An increase in COX-2 protein levels was observed in hippocampal homogenates. *, p<0.05. The piriform cortex (5N-5M) had extensive COX-2 IR at both time points, with a slight increase in the intensity of immunoreactivity in midnight samples (5M). In the hippocampus, COX-2 IR was very low in CA1 (6N -6M) and the dentate gyrus (7N-7M) at both time points, with CA2
and CA3 (8N-8M) exhibiting the majority of COX-2 IR soma in that region. CA2 and CA3 also exhibited a possible increase in fluorescence at midnight (8M) relative to noon (8N), suggesting a potential increase in hippocampal COX-2 at that time point. The amygdala ( 9N-9M) contained a modest number of COX-2 IR soma that did not appear to substantially change between noon and midnight. Scale bar in A = 50 µm. 
the hypothalamus, (5) the amygdala, (6) the thalamus, (7) the hippocampus, (8) the entorhinal cortex, (9) the visual cortex, (10) the periaqueductal gray (PAG), and the cerebellum. 1.20 ± 0.12 midnight 57.2 ± 3.9 26.9 ± 2.4 2.20 ± 0.14** **p<0.01 Table 1 Quantification of COX-2 IR profiles in cortical laminae of the somatosensory and visual cortices. COX-2 IR soma in cortical laminae II/ III and V/ IV were tallied in representative visual fields of 0.0339 mm 2 in mouse brains isolated at both noon and midnight.
In a double-blind analysis, the ratio of immunoreactive profiles in each group of laminae was calculated for each visual field, and the average ratios and standard error calculated for noon and midnight conditions. Three visual fields from each mouse were analyzed, and six mice were examined. Significance was determined by ANOVA. Relative to noon, there was a higher average number of immunoreactive profiles in laminae II and III at midnight, and fewer COX-2 IR profiles in laminae V and VI. This caused the ratio of immunoreactive profiles in laminae II and III / laminae V and VI to significantly (**p<0.01) shift in a positive direction from noon to midnight, indicating a shift in the population of immunoreactive profiles in these cortical regions.
